Target intelligence / Profile preview

Calcineurin B homologous protein 1 (CHP1)

Target
CHP1
Molecular classification
Calcium-binding protein, EF-hand protein, Regulatory cofactor, Enzyme regulator
01

Overview

Calcineurin B homologous protein 1 (CHP1) is a ubiquitously expressed, calcium-binding EF-hand protein that functions primarily as an obligate regulatory cofactor of sodium/hydrogen exchangers, especially NHE1. It is structurally related to calcineurin B and calmodulin and plays important roles in Na+/H+ exchange, membrane trafficking, vesicle targeting and fusion, and cellular pH regulation. CHP1 also participates in the inhibition of the calcineurin/NFAT pathway and gene transcription regulation, and influences processes such as axon maintenance and neurodevelopment. Disruption of CHP1 function may lead to pH dysregulation and neurological disease, reflecting its critical involvement in ion homeostasis and membrane protein trafficking[1][2][3][4].

Other names
Calcineurin like EF-hand protein 1CHPSid470pSLC9A1BPp22p24Calcineurin B-like proteinCalcium-binding protein CHPCalcium-binding protein p22EF-hand calcium-binding domain-containing protein p22Calcineurin homologous proteinSPAX9
02

Mechanism of action

Inhibition of sodium/proton exchange (e.g., cariporide blocks NHE1 activity by preventing conformational change in the NHE1-CHP1 complex)

03

Biological functions

Regulation of Na+/H+ exchangers (NHE, especially NHE1)Membrane traffickingpH homeostasisVesicular traffickingRepression of gene transcription (ribosomal RNA)Inhibition of calcineurin/NFAT signaling
04

Disease associations

Neurological disease (autosomal recessive cerebellar atrophy and ataxia)Spastic ataxia 9Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1Cell survival and apoptosis regulation (less directly in cancer/degeneration)
05

Safety considerations

CHP1 dysfunction may result in impaired neuronal ion homeostasis, neurodegeneration, or impaired cell pH regulationNo direct targeting drugs for CHP1 outside its molecular complex; risk if modulating this pathway includes impairing cell volume regulation
06

Interacting drugs

Cariporide (via its interaction with the NHE1-CHP1 complex)

Beyond the preview

Go deeper on Calcineurin B homologous protein 1 (CHP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcineurin B homologous protein 1 (CHP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call